Security Notice: Please be aware of impersonation attempts using our company name
Legitimate communications from Ascent Research will only come from official @ascentresearch.com email addresses.
Quick Order Cart

Cat. No. ARG38877

DLG1 Knockout HEK293T Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Kidney

The DLG1 Knockout HEK293T Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population derived from HEK293T, providing a heterogeneous loss-of-function model for studying DLG1-dependent processes. This product targets the DLG1 gene, which encodes a MAGUK scaffold critical for organizing signaling complexes at cell junctions and synapses, and regulates Wnt and Hippo pathways. Disruption of DLG1 alters interactions with partners such as CASK and AMPA receptors, impacting cell adhesion, polarity, and proliferation. Applications include investigating neurodevelopmental disorders, cancer metastasis, and junctional signaling through assays like Western blotting, immunofluorescence, and co-immunoprecipitation.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    HEK293T

    Sex of Donor

    Female

    Age

    Fetus

    Derived From Site

    Fetal kidney

    Gene Name

    DLG1

    Gene Identifier

    NCBI Gene ID 1739

    Growth Mode

    Adherent

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    DMEM

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The DLG1 Knockout HEK293T Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population derived from the HEK293T cell line. These cells feature targeted disruption of the DLG1 gene, which encodes the discs large homolog 1 scaffold protein. This polyclonal pool provides a heterogeneous loss-of-function model suitable for investigating DLG1-dependent cellular processes without the limitations of single-cell clonal selection.

HEK293T cells are immortalized human embryonic kidney epithelial cells that constitutively express the SV40 large T-antigen, enabling episomal replication of plasmids containing the SV40 origin of replication. Originally derived from the HEK293 parental line, HEK293T is a widely used host for transient and stable transfections, lentiviral packaging, and protein production due to its high transfectability and robust expression capacity. The cells exhibit adherent growth and rapid proliferation, facilitating scalable experimental workflows.

DLG1 functions as a multidomain scaffold protein of the membrane-associated guanylate kinase (MAGUK) family, orchestrating the assembly of macromolecular signaling complexes at cell?Ccell junctions and synapses. Through its PDZ, SH3, and GUK domains, DLG1 interacts with key partners including CASK, LIN7, and MPP2, and is regulated by upstream kinases such as CaMKII and Src. DLG1 is integral to Wnt and Hippo signaling: it scaffolds Axin, APC, and GSK3B to modulate ??-catenin/TCF/LEF-mediated transcription, and influences YAP/TAZ activity through tight junction?Cassociated complexes. DLG1 also controls AMPA receptor trafficking by binding GRIA1 and GRIA2 subunits, and stabilizes E-cadherin/??-catenin adhesion complexes while regulating PTEN localization and p38 MAPK activation.

Although HEK293T cells do not form fully polarized epithelial monolayers, they express a repertoire of junctional and signaling proteins, making them a convenient system for dissecting DLG1 functions independent of mature epithelial architecture. DLG1 disruption in this background enables focused analysis of Wnt and Hippo pathway transduction, AMPA receptor surface expression, and cytoskeletal rearrangement. The polyclonal knockout format captures a spectrum of genetic perturbations, allowing researchers to assess phenotypic variability and identify robust DLG1-dependent mechanisms.

These cells are suitable for a wide range of experimental approaches, including Western blotting and immunofluorescence to confirm protein loss and localization, co-immunoprecipitation and RT-qPCR to assess protein interactions and transcript levels. Further functional assays include TOPFlash or TEAD reporter assays to measure Wnt and Hippo pathway activity, cell migration and proliferation assays to model tumor suppression, and flow cytometry for surface receptor analysis. The model supports investigations into neurodevelopmental disorders, inflammatory bowel disease, and cancer metastasis. For further details, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)